Samantha Perez, Phd Email & Phone Number

New Haven, CT, US

Virginia, United States

• Involved in all aspects of scientific program strategy and lab operations in evaluating early-stage drug development projects spanning various modalities, including functional antibody, T-cell engager.
• Developed protocols, managed work orders, and led day-to-day oversight of biologic drug discovery campaigns and in vitro/in vivo preclinical studies at over 40 CROs that total 104 projects worth $3M
• Mentored and supervised two research associates in optimizing and troubleshooting molecular and cell biology assays across various R&D programs
• Delivered impactful presentations on scientific progress to the Board of Directors and Scientific Advisory Board
• Authored non-confidential and confidential reports and presentations for potential investors and strategic partners

Virginia, United States

• Extensive experience in designing, executing, analyzing, interpreting, and troubleshooting cell-based pharmacological assays and in vivo models to evaluate mechanism of action, exploratory biomarkers, and efficacy of.
• Synthesized available data, expertise from subject-matter experts, and published literature to facilitate decision-making and meet corporate goals
• Contributed significantly to the development and implementation of patient selection and clinical biomarker strategies for ZielBio’s Phase 1 clinical trial, including immunophenotyping patient biopsies by multiplex-IF
• Presented scientific updates to corporate leadership and at cross-functional project team meetings
• Co-authored and reviewed two successful Orphan Drug Designation applications as well as multiple national conference presentations, peer-reviewed articles, and press releases

Charlottesville, Virginia Area

• Faculty Advisor: Kimberly Kelly, Ph.D.
• Evaluated therapeutic targeting of cell-surface plectin with a tool antibody as a novel anti-cancer strategy
• Designed and executed extensive in-vitro/in-vivo efficacy and MOA studies
• Contributed research findings to a successful Investigational New Drug (IND) application
• Secured over $160,000 in dissertation funding during academic tenure (Robert Wood Johnson Foundation, Achievement Rewards for College Scientists, Society of Hispanic Professional Engineers (SHPE), Hispanic Scholarship.

Secured a prestigious $120,000 national grant to leverage biomedical research findings to inform policy decisions aimed at dismantling cancer health disparities

Raleigh-Durham, North Carolina Area

• Faculty Advisors: William M. Reichert, Ph.D. & George A. Truskey, Ph.D.
• Received the Pratt Research Fellowship to research strategies for enhancing extracellular matrix production in tissue-engineered blood vessels
• Presented research findings at national conferences, including the Biomedical Engineering Society's annual meeting (BMES) and SHPE's annual convention, and published in a peer-reviewed journal
• Honored with the Helmholtz Award, which recognizes the top undergraduate research project in the engineering school

Raleigh-Durham, North Carolina Area

• Faculty Advisor: William M. Reichert, Ph.D.
• Generated stable co-cultures to act as 2D vascular wall models for tissue-engineered blood vessels
• Evaluated the effects of various tool compounds on 2D co-culture stability.

Greater Los Angeles Area

• Advisors: Jeffrey Ohmen, Ph.D. & Rick Friedman, M.D., Ph.D.
• Examined the effects of a high-fat diet on age-related hearing loss in mice
• Researched how processes of systemic aging impact hearing impairment

Doctor Of Philosophy - Phd, Biomedical Engineering

Activities and Societies: Raven Society Dissertation: Therapeutic Targeting of Cancer-Specific Plectin is a Novel and Potent Antitumor.

Bachelor Of Science In Engineering, Biomedical Engineering

Education record

Education record

Bachelor Of Science - Bs